Xechem International Inc. (fka XKEM)

[lsd673]

We are exploring a network to develop new medicines for neglected developing world diseases...

Statement to WHO Executive Board
24 January 2008 Geneva,Switzerland

R&D-based Pharmaceutical Industry’s Growing Engagement
in Health Partnerships for the Developing World

International Federation of Pharmaceutical Manufacturers & Associations


• A Network for Neglected Disease Discovery. We are exploring a network to develop new medicines for neglected developing world diseases, through sharing of disease targets between industry and other research groups, allowing them to be screened against company compound libraries. Work is currently focused on defining detailed operating principles and adding to the number of companies that have already agreed to collaborate.

• A Sustainable R&D Funding Initiative. This aims to lay the foundations for adequate,
sustainable and predictable funding for R&D into neglected diseases, through realistic
estimation of additional funding needed to complete the portfolios required to deliver
sufficient numbers of new medicines, and evaluation of appropriate mechanisms for raising
funds, prioritizing their allocation and governance. It is also working to raise awareness and
build consensus amongst R&D organizations, potential donors and other stakeholders.

• A Capacity Development Program. Industry recognizes the serious impact of shortfalls in
health care and regulatory capacity in many developing countries and is looking at
harnessing industry and other expert resources help build capacity in affected areas.

http://www.ifpma.org/pdf/2008_01_24_Statement_to_EB.pdf